Categories
 
Shopping Cart
0 items
 

PHARMACEUTICAL, DRUGS, AYURVEDIC MEDICINES

Sort By:
AEROSOL SPRAY FOR PHARMACEUTICAL USE
AEROSOL SPRAY FOR PHARMACEUTICAL USE
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

MARKET SURVEY CUM DETAILED TECHNO
ECONOMIC FEASIBILITY REPORT covers
 
Introduction
Uses and Applications
Properties
Market Survey with future aspects
Present Manufacturers
Detailed Process of Manufacture
Formulations
B.I.S. Specifications
Process Flow Sheet Diagram, Plant Layout,
Cost Economics with Profitability Analysis
Capacity
Land & Building Requirements with Rates.... read more

ALOE VERA PROCESSING
ALOE VERA PROCESSING
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

MARKET  SURVEY CUM  DETAILED  TECHNO 
ECONOMIC FEASIBILITY  REPORT

covers

Introduction
Uses and  Applications
Properties
Market Position
Present Manufacturers 
Detailed  Process of  Manufacture 
Formulations
B.I.S. Specifications
Process Flow Sheet Diagram, Plant  Layout,
Cost  Economics  with Profitabi.... read more

ALOEVERA JUICE AND GEL
ALOEVERA JUICE AND GEL
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:


                                                       ALOEVERA JUICE AND GEL


Aleo barbadensis, popularly known as Aleo Vera originated in  t.... read more

AMPICILLIN TRIHYDRATE IN CAP.
AMPICILLIN TRIHYDRATE IN CAP.
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

MARKET SURVEY CUM DETAILED TECHNO
ECONOMIC FEASIBILITY REPORT covers
 
Introduction
Uses and Applications
Properties
Market Survey with future aspects
Present Manufacturers
Detailed Process of Manufacture
Formulations
B.I.S. Specifications
Process Flow Sheet Diagram, Plant Layout,
Cost Economics with Profitability Analysis
Capacity
Land & Building Requirements with Rates.... read more

AROMATIC PILLS
AROMATIC PILLS
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

MARKET  SURVEY CUM  DETAILED  TECHNO 
ECONOMIC FEASIBILITY  REPORT covers
 

Introduction
Uses and  Applications
Properties
Market   Survey  with   future   aspects 
Present Manufacturers 
Detailed  Process of  Manufacture 
Formulations
B.I.S. Specifications
Process Flow Sheet Diagram, Plant  .... read more

ASPIRIN
ASPIRIN
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

                                                             ASPIRIN

Pain is perhaps the most universal of man’s experi.... read more

AYURVEDIC CHURAN & TABLETS
AYURVEDIC CHURAN & TABLETS
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

MARKET  SURVEY CUM  DETAILED  TECHNO 
ECONOMIC FEASIBILITY  REPORT covers
 

Introduction
Uses and  Applications
Properties
Market   Survey  with   future   aspects 
Present Manufacturers 
Detailed  Process of  Manufacture 
Formulations
B.I.S. Specifications
Process Flow Sheet Diagram, Plant  .... read more

AYURVEDIC MEDICINES
AYURVEDIC MEDICINES
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

MARKET  SURVEY CUM  DETAILED  TECHNO 
ECONOMIC FEASIBILITY  REPORT covers
 

Introduction
Uses and  Applications
Properties
Market   Survey  with   future   aspects 
Present Manufacturers 
Detailed  Process of  Manufacture 
Formulations
B.I.S. Specifications
Process Flow Sheet Diagram, Plant  .... read more

AYURVEDIC PAIN BALM OINTMENTS
AYURVEDIC PAIN BALM OINTMENTS
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

                               AYURVEDIC PAIN BALM OINTMENT (EIRI-1000)

During the last few decades and especially after the emergence of Rauvolfia serpentina as the “Wonder Drug of India”, there is a steady effort in and outside the country to screen Ayurvedic drugs for their t.... read more

AYURVEDIC PRODUCTS
AYURVEDIC PRODUCTS
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

MARKET  SURVEY CUM  DETAILED  TECHNO 
ECONOMIC FEASIBILITY  REPORT covers
 

Introduction
Uses and  Applications
Properties
Market   Survey  with   future   aspects 
Present Manufacturers 
Detailed  Process of  Manufacture 
Formulations
B.I.S. Specifications
Process Flow Sheet Diagram, Plant  .... read more

AYURVEDIC TABLETS (HAJMOLA TYPE)
AYURVEDIC TABLETS (HAJMOLA TYPE)
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

MARKET SURVEY CUM DETAILED TECHNO
ECONOMIC FEASIBILITY REPORT covers

 
•            Introduction
•            Properties
•            BIS (Bureau of Indian Standard) Specifications & Requirements
•      .... read more

AYURVEDIC/HERBAL PHARMACY
AYURVEDIC/HERBAL PHARMACY
ISBN Number:PROJECT REPORT
Price: Request Price/Send Enquiry
Description:

MARKET  SURVEY CUM  DETAILED  TECHNO 
ECONOMIC FEASIBILITY  REPORT covers
 

Introduction
Uses and  Applications
Properties
Market   Survey  with   future   aspects 
Present Manufacturers 
Detailed  Process of  Manufacture 
Formulations
B.I.S. Specifications
Process Flow Sheet Diagram, Plant  .... read more

The Indian Pharmaceutical Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously.

Playing a key role in promoting and sustaining development in the vital field of medicines, Indian Pharma Industry boasts of quality producers and many units approved by regulatory authorities in USA and UK. International companies associated with this sector have stimulated, assisted and spearheaded this dynamic development in the past 53 years and helped to put India on the pharmaceutical map of the world.

Growth Scenario in 2010

India's pharmaceutical industry is now the third largest in the world in terms of volume. Its rank is 14th in terms of value. Between September 2008 and September 2009, the total turnover of India's pharmaceuticals industry was US$ 21.04 billion. The domestic market was worth US$ 12.26 billion. This was reported by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. As per a report by IMS Health India, the Indian pharmaceutical market reached US$ 10.04 billion in size in July 2010. A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually. Know more out this in our article on Indian Pharmaceutical Industry- Future Trends Also check out Pharmaceutical Market Trends 2010

Leading Pharmaceutical Companies


In the domestic market, Cipla retained its leadership position with 5.27 per cent share. Ranbaxy followed next. The highest growth was for Mankind Pharma (37.2%). Other leading companies in the Indian pharma market in 2010 are:

    Sun Pharma (25.7%)
    Abbott (25%)
    Zydus Cadila (24.1%)
    Alkem Laboratories (23.3%)
    Pfizer (23.6 %)
    GSK India (19%)
    Piramal Healthcare (18.6 %)
    Lupin (18.8 %)


For details check out List of Top 10 Pharmaceutical Companies in India

Future Prospects


The Indian pharmaceuticals market is expected to reach US$ 55 billion in 2020 from US$ 12.6 billion in 2009. This was stated in a report title "India Pharma 2020: Propelling access and acceptance, realising true potential" by McKinsey & Company. In the same report, it was also mentioned that in an aggressive growth scenario, the pharma market has the further potential to reach US$ 70 billion by 2020

Due to increase in the population of high income group, there is every likelihood that they will open a potential US$ 8 billion market for multinational companies selling costly drugs by 2015. This was estimated in a report by Ernst & Young. The domestic pharma market is estimated to touch US$ 20 billion by 2015. The healthcare market in India to reach US$ 31.59 billion by 2020. The sale of all types of pharmaceutical drugs and medicines in the country stands at US$ 9.61 billion, which is expected to reach around US$ 19.22 billion by 2012. Thus India would really become a lucrative destination for clinical trials for global giants.

There was another report by RNCOS titled "Booming Pharma Sector in India" in which it was projectedt that the pharmaceutical formulations industry is expected to prosper in the same manner as the pharmaceutical industry. The domestic formulations market will grow at an annual rate of around 17% in 2010-11, owing to increasing middle class population and rapid urbanisation. Read More in Future Prospects of Indian Pharma Industry.

Characteristics of Indian Pharmaceutical Industry
The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control.

The pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectibles. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations.

Following the de-licensing of the pharmaceutical industry, industrial licensing for most of the drugs and pharmaceutical products has been done away with. Manufacturers are free to produce any drug duly approved by the Drug Control Authority. Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade. The Pharmaceutical Industry, with its rich scientific talents and research capabilities, supported by Intellectual Property Protection regime is well set to take on the international market.

Why India?


Competent workforce: India has a pool of personnel with high managerial and technical competence as also skilled workforce. It has an educated work force and English is commonly used. Professional services are easily available.

Cost-effective chemical synthesis: Its track record of development, particularly in the area of improved cost-beneficial chemical synthesis for various drug molecules is excellent. It provides a wide variety of bulk drugs and exports sophisticated bulk drugs.

Legal & Financial Framework: India has a 53 year old democracyand hence has a solid legal framework and strong financial markets. There is already an established international industry and business community.

Information & Technology: It has a good network of world-class educational institutions and established strengths in Information Technology.

Globalisation: The country is committed to a free market economy and globalization. Above all, it has a 70 million middle class market, which is continuously growing.

Consolidation: For the first time in many years, the international pharmaceutical industry is finding great opportunities in India. The process of consolidation, which has become a generalized phenomenon in the world pharmaceutical industry, has started taking place in India.

Steps to strengthen the Industry


Indian companies need to attain the right product-mix for sustained future growth. Core competencies will play an important role in determining the future of many Indian pharmaceutical companies in the post product-patent regime after 2005. Indian companies, in an effort to consolidate their position, will have to increasingly look at merger and acquisition options of either companies or products. This would help them to offset loss of new product options, improve their R&D efforts and improve distribution to penetrate markets.

Research and development has always taken the back seat amongst Indian pharmaceutical companies. In order to stay competitive in the future, Indian companies will have to refocus and invest heavily in R&D.

The Indian pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, its forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisitions, co-marketing and licensing agreements.

 
Privacy Policy Claims and Refunds Terms Of Use Other Site